Anesthesia devices Market size was valued at USD 16.41 Billion in 2023 and is likely to cross USD 52.76 Billion by the end of 2036, registering more than 9.4% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of anesthesia devices is estimated at USD 17.8 Billion. The market growth is primarily driven by a higher number of people suffering from cardiovascular diseases, cancer, and others. Moreover, the increasing prevalence of chronic diseases such as cardiovascular disease, cancer, and others is leading to a higher demand for surgical procedures, which in turn is driving the demand for anesthesia devices. In the United States, cardiovascular disease claims one life every 34 seconds. Moreover, every 1 in 5 deaths in the United States in 2020 was caused by heart disease, which claimed about 7000,000 lives. Furthermore, in 2020, there were around 18,0oo billion new cancer cases reported worldwide. In 2020, the combined age-standardized rate for all malignancies, excluding non-melanoma skin cancer, was 190 per 100,000.
Additionally, the aging population and the increasing adoption of minimally invasive surgical procedures are also driving anesthesia devices market growth. Minimally invasive procedures, such as laparoscopic surgery, require the use of specialized anesthesia devices, which is contributing to the growth of the market. Besides this, the global anesthesia market growth is also attributed to a higher number of surgical procedures performed, which can be done for many causes, including cancer, organ transplantation, bypass surgery, and others. According to the estimates, around 129,681 organ transplants took place globally in 2020. The kidney, liver, and heart are the three organs that are transplanted the most globally. Furthermore, nearly 60% of cancer cases require surgical care, and around 17 million die every year globally from a lack of timely surgical care. In addition, nearly 90% of maternal deaths can be prevented by the intervention of obstetric surgery.
Growth Drivers
Challenges
|
Base Year |
2023 |
|
Forecast Year |
2024-2036 |
|
CAGR |
9.4% |
|
Base Year Market Size (2023) |
USD 16.41 Billion |
|
Forecast Year Market Size (2036) |
USD 52.76 Billion |
|
Regional Scope |
|
End-user (Hospitals, Ambulatory Surgical Centers)
The global anesthesia devices market is segmented and analyzed for demand and supply by the end user into hospitals, ambulatory surgical centers, and others. Out of all, the hospital segment is anticipated to hold the largest market size by the end of 2036. The segment’s growth is expected on account of the rise in the number of hospitals and the need for individuals to receive treatment in hospitals. Moreover, people are opting for hospitals in order to have surgical procedures with better medical facilities, and this is expected to surge the segment’s growth in the market. There were over 8,000 hospitals in Japan as of 2020. Korea, by contrast, had about 4,000 hospitals. In addition, there were more than 6000 hospitals in the US.
Product Type (Basic Anesthesia Monitors, Integrated Anesthesia Workstations, Disposables)
The global anesthesia devices market is also segmented and analyzed for demand and supply by product type into basic anesthesia monitors, integrated anesthesia workstations, and disposables. Out of these segments, the integrated anesthesia workstations segment is expected to garner the largest share of the market by the end of 2036. Integrated anesthesia workstations are customized medical carts that contain a ventilator, an anesthetic machine, and monitoring tools. The use of these–in–solutions is expected to grow as surgical procedures grow in number globally, which can be owed to chronic diseases, road accidents, and other cases which require surgical medical attention. For instance, it is estimated that over 1.25 million people die every year owing to road accidents across the globe.
.Our in-depth analysis of the global anesthesia devices market includes the following segments:
|
By Product Type |
|
|
By End User |
|
North America Market Forecast
The North America anesthesia devices market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2036. The North American market growth is expected on the account of a higher number of people suffering from chronic disease and a higher number of people who need organ transplantation. Organ transplants are often required in lifesaving situations and surgeries when a disease or illness progresses to later stages. The burden of chronic diseases is increasing in the U.S. as a result of a sedentary lifestyle, rising disposable income, and a higher life expectancy. Such diseases have become a leading cause of mortality. As per the statistics of the Centers for Disease Control and Prevention, 6 out of 10 U.S. adults are living with a chronic illness and every 4 out of 10 people have at least 1 chronic condition. Moreover, there are currently close to 121,000 people in need of kidney transplants in the United States.
Furthermore, in the US, the prevalence of diseases, including cancer and cardiovascular conditions is rising quickly. Nearly half of Americans, including those with hypertension, coronary heart disease, etc., had some form of cardiovascular disease, according to data from the American Heart Association that was released in January 2019. These illnesses usually necessitate procedures such as angioplasty, bypass, and so on, which helps to fuel the market for anesthetic devices rising demand. Additionally, according to GLOBOCON 2020, there were 612,390 fatalities and 2,281,658 new cancer cases reported in the United States in 2020. The increasing incidence of cancer cases suggests the need for more cancer-related surgeries and cancer services which are estimated to raise the need for anesthetic equipment in the area. Hence, it is predicted to surge the growth of the market in the region.
Philips and B. Braun announced the FDA approval for Onvision. It is an innovative ultrasound guidance setup for keeping track of needle tips.
GE Healthcare received the FDA clearance for the breakthrough software that enables the automation of anesthesia delivery and the reduction of greenhouse gas emissions during surgery.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?